- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 274
SamanTree branches out with $9.3m
Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.
May 8, 2019Rfrnz reaches seven-digit understanding
TUM automated legal analysis spinout Rfrnz has secured backing from Unternehmertum-operated Initiative for Industrial Innovations, HTGF and unnamed additional investors.
May 8, 2019Dynabind dines on seed financing
TU Dresden-founded drug discovery platform operator Dynabind has advanced research from the lab of Yixin Zhang in the university’s B Cube Center for Molecular Bioengineering.
May 8, 2019Psyomics opens up to seed funding
Psyomics has added an undisclosed seed sum to capital previously raised from Parkwalk Advisors-managed vehicles Opportunities Fund and University of Cambridge Enterprise Fund.
May 8, 2019Confo confirms $33.4m
The funding, provided by investors including Qbic, will allow VUB and VIB spinout Confo Therapeutics to accelerate its drug discovery efforts and move towards clinical trials.
May 8, 2019Kasada infiltrates $4.6m
Csiro Innovation Fund joined Westpac-backed Reinventure to co-lead cybersecurity platform creator Kasada’s latest round, which will help fund recruitment and international expansion.
May 8, 2019Mirdetect spots seven-digit seed round
A consortium involving public-private partnership HTGF has supplied funding to University of Bremen spinout Mirdetect to help a molecular diagnostics blood draw for testicular cancer.
May 7, 2019Hy2Care caresses $4.1m
University of Twente-founded cartilage repair injection developer Hy2Care is currently targeting orthopaedic knee applications in veterinary and human healthcare settings.
May 7, 2019Stanford-StartX Fund court saga rumbles on
The university faces accusations it used Stanford-StartX Fund to illegally pursue a profit-led investment strategy while using its own funds and personnel to protect the applicability of its tax exemptions as a nonprofit institution.
May 7, 2019OssDsign prepares public listing
Regenerative implant producer OssDsign, based on research at Karolinska University Hospital and Uppsala University, hopes to list on the Nasdaq First North and raise $15.8m.
May 7, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


